The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options.
The approval of Bright Uro’s Glean abdominal sensor advances the capabilities of its broader Glean urodynamics system that gained FDA approval in March 2025.
With FDA clearance in hand, Rivanna highlighted that it will accelerate the development of further AI capabilities for the Accuro XV system.
FORT LAUDERDALE, Fla., May 7, 2026 /PRNewswire/ — Spinal Resources, Inc., a developer of advanced spinal stabilization technologies, today announced the issuance of U.S. Patent No. 12,611,231, “Spinal Rod and Systems Thereof”.
Microsure announced today that it received CE mark approval for its MUSA-3 surgical robot and named Alex Joseph as CEO.
Sweden-based Multi4 Medical has received CE mark approval for its Multi4 System, an all-in-one endoscopic instrument designed to enable bladder cancer treatment during the same outpatient visit when cancer is detected.
ADDISON, Texas, May 5, 2026 /PRNewswire/ — FX Shoulder Solutions, Inc. has received FDA 510(k) clearance for the FX V135® Easytech Shoulder System, the next generation of stemless shoulder arthroplasty implants that provides surgeons with an anatomic stemless versus a modular stemmed-reverse option. This design enables surgeons to begin with a stemless approach and, when clinically appropriate, transition intraoperatively to a short stem solution without changing or adding another system.
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its VitalFlow Transport Frame Air and Ground (AG) accessory.
TaeWoong Medical, the fully covered, self-expanding metallic device, is intended to aid EUS drainage procedures.
Philips (NYSE:PHG) announced that it received FDA 510(k) clearance for its Smart Fit TorsoCardiac magnetic resonance (MR) 1.5T coil.